ELK1 promotes the progress of myeloid leukemia by hindering the differentiation of neutrophils
Our study demonstrates that ELK1 is a potential therapeutic target for AML, due to its critical role in regulating neutrophils differentiation.
Authors
- Yuhan He (ORCID: https://orcid.org/0000-0001-5429-9480)
- Yong Dong (ORCID: https://orcid.org/0000-0003-4058-3610)
- Sizhou Huang (ORCID: https://orcid.org/0000-0002-1739-8225)
- D.S. Wen
- Rongqun Guo
- Juan Du
- Ya Zhou
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Chengdu Medical College (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- First Affiliated Hospital of Jinan University (CN)
Publication Details
- Journal
- Experimental Hematology and Oncology
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1186/s40164-025-00742-4
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00